6
Rapid Lateral Flow Assays Rapid lateral flow tests were adopted at an unprecedented scale during the COVID-19 pandemic, enabling access to testing beyond healthcare settings 3 . SARS-CoV-2 antigen rapid tests were developed within months and in 2022, the WHO ‘strongly endorsed’ COVID-19 self-testing with rapid tests 4 , putting the public at the heart of the public health response. By late 2022, more than 3 billion tests for SARS-CoV-2 had been conducted worldwide 5 .
Figure 5. Timeline of key advances in lateral flow testing.
Retrieved from: Budd, J., Miller, B.S., Weckman, N.E. et al. (2023) Lateral flow test engineering and lessons learned from COVID-19. Nat Rev Bioeng 1, 13–31. https://doi.org/10.1038/s44222-022-00007-3
Powered by FlippingBook